Table 2.
Comparison of CMR findings between LVEF-recovered and -unrecovered PPCM patients
| Recovered (n = 10) | Unrecovered (n = 11) | P values | |
|---|---|---|---|
| Age, years | 27.5 ± 5.9 | 29.3 ± 6.0 | 0.505 |
| BMI (kg/m2) | 22.2 ± 2.3 | 21.9 ± 5.3 | 0.852 |
| SBP (mmHg) | 106.8 ± 9.0 | 99.7 ± 8.5 | 0.079 |
| DBP (mmHg) | 73.4 ± 12.1 | 63.3 ± 6.0 | 0.023 |
| HR (beat/min) | 89.2 ± 18.7 | 83.7 ± 14.6 | 0.461 |
| NYHA class | 0.771 | ||
| II/III/ IV, n | 2/5/3 | 1/6/4 | |
| Lab | |||
| HCT (%) | 41.6 ± 3.8 | 39.5 ± 4.6 | 0.280 |
| NT-proBNP (pg/ml) | 1451.5 [470.0, 3398.5] | 2243.0 [1817.0, 5976.0] | 0.387 |
| TnT(ng/L) | 10.1 [2.8, 14.7] | 12.5 [7.2, 25.6] | 0.236 |
| CMR findings | |||
| LVEDVI (ml/m2) | 150.9 ± 24.0 | 158.1 ± 38.0 | 0.615 |
| LVEF (%) | 29.3 ± 11.2 | 24.5 ± 10.1 | 0.317 |
| LVMI (g) | 70.4 ± 9.3 | 76.5 ± 21.0 | 0.405 |
| RVEDVI (ml/m2) | 118.8 ± 38.8 | 122.5 ± 44.6 | 0.845 |
| RVEF (%) | 34.3 ± 15.7 | 33.5 ± 14.4 | 0.900 |
| LGE, n (%) | 2 (20) | 6 (54.5) | 0.119 |
| ECV (%) | 30.7 ± 2.1 | 36.8 ± 5.6 | 0.005 |
| Native T1 (ms) | 1301 ± 71 | 1385 ± 66 | 0.011 |
| Post T1 (ms) | 487 ± 77 | 418 ± 40 | 0.018 |
| T2 (ms) | 40.6 ± 3.0 | 43.9 ± 3.7 | 0.040 |
| Medications | |||
| ACEI/ARB, n (%) | 9 (90) | 11 (100) | 0.476 |
| β blocker, n (%) | 10 (100) | 9 (81.8) | 0.476 |
| Antisterone, n (%) | 10 (100) | 11 (100) | NA |
| Diuretic, n (%) | 8 (80) | 10 (90.9) | 0.586 |
Abbreviations: ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin II receptor blockers, others are the same as in Table 1